ARTICLE | Company News

Sanofi pharmaceuticals news

July 20, 2015 7:00 AM UTC

Sanofi will reorganize into five global business units. The realignment is Sanofi’s first major move since Olivier Brandicourt took over as CEO in April.

Peter Guenter, Sanofi’s EVP of global commercial operations, will lead the general medicines and emerging markets unit. The unit will include Sanofi’s established products, generics and consumer healthcare businesses, plus pharmaceutical businesses in emerging markets. ...